SBL
TEVA icon

Sargent Bickham Lagudis’s Teva Pharmaceuticals TEVA Stock Holding History

Sargent Bickham Lagudis’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-350
Closed -$7K – 804
2017
Q4 		$7K Hold
350
– – ﹤0.01% 657
2017
Q3 		$6K Hold
350
– – ﹤0.01% 683
2017
Q2 		$12K Hold
350
– – ﹤0.01% 552
2017
Q1 		$11K Hold
350
– – ﹤0.01% 581
2016
Q4 		$13K Sell
350
-202
-37% -$8.06K ﹤0.01% 529
2016
Q3 		$25 Sell
552
-448
-45% -$23.4K ﹤0.01% 451
2016
Q2 		$40K Hold
1,000
– – 0.01% 371
2016
Q1 		$40K Buy
+1,000
New +$58.7K 0.01% 397

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return